Jian Cao

Title: Jian Cao: Innovator in Matrix Metalloproteinase Inhibitors

Introduction

Jian Cao is a prominent inventor based in Setauket-East Setauket, NY (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target matrix metalloproteinases, which are crucial in various disease processes, including cancer. With a total of 4 patents to his name, his work continues to influence therapeutic strategies.

Latest Patents

Cao's latest patents include innovative compounds designed as inhibitors of the hemopexin domain of matrix metalloproteinase-9 (MMP-9). One of his notable inventions is titled "Substituted pyrimidines as matrix metalloproteinase-9 hemopexin domain inhibitors." This invention relates to substituted pyrimidine compounds that selectively target the hemopexin domain of MMP-9 without inhibiting its catalytic functions. The invention also outlines methods for treating cancer in patients using these compounds. Another significant patent is "Substituted quinazolines as matrix metalloproteinase-9 hemopexin domain inhibitors," which further expands the arsenal of therapeutic options against MMP-9.

Career Highlights

Jian Cao is affiliated with the State University of New York, where he conducts research and develops innovative solutions in the field of biochemistry and pharmacology. His academic and research endeavors have positioned him as a key figure in the study of matrix metalloproteinases and their role in disease.

Collaborations

Cao has collaborated with notable colleagues, including Iwao Ojima and Vincent Alford, enhancing the breadth and impact of his research through shared expertise and insights.

Conclusion

Jian Cao's contributions to the field of medicinal chemistry, particularly through his patents on matrix metalloproteinase inhibitors, highlight his role as an influential inventor. His work not only advances scientific understanding but also holds promise for developing new cancer therapies.